Northern Trust’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.5M | Sell |
1,121,892
-1,064
| -0.1% | -$34.6K | 0.01% | 1288 |
|
|
2025
Q1 | $42.4M | Sell |
1,122,956
-37,045
| -3% | -$1.4M | 0.01% | 1182 |
|
|
2024
Q4 | $95M | Buy |
1,160,001
+123,584
| +12% | +$10.1M | 0.01% | 743 |
|
|
2024
Q3 | $118M | Buy |
1,036,417
+96,691
| +10% | +$11M | 0.02% | 592 |
|
|
2024
Q2 | $71M | Sell |
939,726
-29,031
| -3% | -$2.19M | 0.01% | 790 |
|
|
2024
Q1 | $66.2M | Buy |
968,757
+84,489
| +10% | +$5.77M | 0.01% | 822 |
|
|
2023
Q4 | $55.5M | Sell |
884,268
-12,367
| -1% | -$777K | 0.01% | 935 |
|
|
2023
Q3 | $45.7M | Buy |
896,635
+35,694
| +4% | +$1.82M | 0.01% | 1009 |
|
|
2023
Q2 | $43M | Buy |
860,941
+192,639
| +29% | +$9.62M | 0.01% | 1061 |
|
|
2023
Q1 | $25M | Buy |
668,302
+8,971
| +1% | +$336K | 0.01% | 1405 |
|
|
2022
Q4 | $31.6M | Buy |
659,331
+175,439
| +36% | +$8.41M | 0.01% | 1225 |
|
|
2022
Q3 | $11.6M | Buy |
483,892
+19,555
| +4% | +$469K | ﹤0.01% | 1879 |
|
|
2022
Q2 | $10.1M | Buy |
464,337
+82,212
| +22% | +$1.79M | ﹤0.01% | 2026 |
|
|
2022
Q1 | $9.23M | Buy |
382,125
+10,663
| +3% | +$258K | ﹤0.01% | 2196 |
|
|
2021
Q4 | $8.84M | Sell |
371,462
-3,645
| -1% | -$86.7K | ﹤0.01% | 2320 |
|
|
2021
Q3 | $9.52M | Buy |
375,107
+9,455
| +3% | +$240K | ﹤0.01% | 2310 |
|
|
2021
Q2 | $8.23M | Buy |
365,652
+74,694
| +26% | +$1.68M | ﹤0.01% | 2504 |
|
|
2021
Q1 | $5.75M | Buy |
290,958
+67,838
| +30% | +$1.34M | ﹤0.01% | 2668 |
|
|
2020
Q4 | $5.93M | Buy |
223,120
+8,593
| +4% | +$228K | ﹤0.01% | 2576 |
|
|
2020
Q3 | $10.6M | Buy |
+214,527
| New | +$10.6M | ﹤0.01% | 2082 |
|